Genmab A GNMSF
NASDAQ GNMSF
$335.00 +15.00 (+4.69%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genmab A/S (GNMSF) Debt Ratio (2019 - 2026)

Genmab A's (GNMSF) quarterly Debt Ratio came in at 0.4 in Q1 2026, up 1735.76% YoY from 0.02 in Q1 2025, and down 2.71% on a QoQ basis from 0.41 in Q4 2025.

Genmab A/S (GNMSF) Debt Ratio (2019 - 2026) Analysis & Trends

Genmab A (GNMSF) has 4 years of Debt Ratio data on file, last reported at 0.4 in Q1 2026.

  • Quarterly Debt Ratio rose 1735.76% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (up 1735.76% YoY) and the FY2025 annual result came in at 0.41, changed N/A from the prior year.
  • Debt Ratio fell to 0.4 in Q1 2026, from 0.41 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.41 in Q4 2025 to a low of 0.02 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 0.41
Mar 31, 2026 0.40
Dec 31, 2025 0.41
Mar 31, 2025 0.02
Sep 30, 2020 0.00
Dec 31, 2019 12,038.58
Sep 30, 2019 0.00